The Department of Cardiovascular Medicine at The Second Norman Bethune Hospital of Jilin University is a National Key Clinical Specialty Construction Project, a Clinical Key Specialty designated by the Jilin Provincial Health Department, an interventional cardiology center appointed by the Jilin Provincial Health Department, the Cardiovascular Disease Diagnosis and Treatment Center of Jilin University, one of the first Ministry of Health-certified training bases for coronary interventional therapy, one of the first Ministry of Health-certified training bases for arrhythmia interventional therapy, the Jilin Provincial Coronary Intervention Quality Control Center under the Ministry of Health, and a national clinical drug trial base. It is a comprehensive department integrating medical care, teaching, scientific research, and prevention. It holds a leading position in the diagnosis and treatment of cardiovascular diseases within the province, serves as the leading department in the field of interventional cardiology in Jilin Province, and enjoys a high reputation in Northeast China and even nationwide.

The Department of Cardiovascular Medicine boasts a group of nationally renowned experts and professors with superb medical skills, as well as world-class advanced diagnostic and therapeutic equipment. The department currently has 8 professors and chief physicians, 9 associate professors and associate chief physicians, 2 doctoral supervisors, and 13 master's supervisors.

Professor Liu Bin, the academic leader of the department, also serves as a member of the Chinese Society of Pacing and Electrophysiology (CSPE) of the Chinese Medical Association, a youth member of the Chinese Society of Cardiology of the Chinese Medical Association, a youth member of the Rhythm Society of the Chinese Society of Biomedical Engineering, a standing committee member of the Chinese College of Cardiovascular Physicians, a member of the Heart Failure Professional Group of the Chinese Society of Cardiology of the Chinese Medical Association, a member of the Expert Guidance Committee for the Management Standards of Interventional Diagnosis and Treatment Techniques for Arrhythmias of the Chinese Medical Association, a review expert for the National Natural Science Foundation of China, director of the Jilin Provincial Coronary Intervention Quality Control Center under the Ministry of Health, mentor of the Ministry of Health’s Cardiovascular Disease Interventional Diagnosis and Treatment Training Base, vice chairman of the Jilin Provincial Association of Integrative Medicine Atherosclerosis Professional Committee, chairman of the Jilin Provincial Society of Pacing and Electrophysiology of the Chinese Medical Association, chairman of the Outstanding Specialty Society of the Jilin Provincial Medical Association, council member of the Jilin Provincial Medical Association, vice chairman of the Jilin Provincial Doctor Association’s Evidence-Based Medicine Professional Committee, medical accident technical appraisal expert of the Changchun Medical Association, and visiting professor of Medtronic University’s Cardiac Rhythm Disease Management College. He also serves as executive editorial board member of the Chinese Journal of Modern Internal Medicine and Chinese Journal of Laboratory Diagnosis. Due to his outstanding personal achievements, he has been honored with titles such as the second-level "Top Innovative Talent" in the Jilin Provincial health system, one of the Top Ten Physicians of Jilin University, one of the Top Ten Outstanding Youths of Jilin University, and the Eighth Jilin Provincial Youth Science and Technology Award.

The department currently has 4 patient areas and 1 intensive care unit, with 216 beds. It boasts first-class ward facilities and medical equipment, including a cardiovascular outpatient clinic, cardiac ultrasound, cardiovascular function room, cardiovascular wards (including a CCU), and a cardiac catheterization laboratory. It has two domestically leading cardiovascular interventional catheterization rooms equipped with the world’s most advanced large-scale cardiovascular interventional diagnosis and treatment systems and various other medical equipment, including: Siemens digital subtraction flat-panel vascular angiography machines, 64-lead electrophysiology recorders, 3D mapping and navigation systems (CARTO), intravascular ultrasound, FFR, cardiac program stimulators and hemodynamic monitoring systems, external temporary pacemakers, radiofrequency ablation instruments, IABP, large ultra-low temperature centrifuges, gel imaging systems, treadmill systems, defibrillators, color ultrasound diagnostic systems, central monitoring systems, and multi-lead electrophysiology recorders.

The Department of Cardiovascular Medicine has extensive clinical experience in the treatment of critically ill and complex cardiovascular diseases. It was the first in Jilin Province to carry out a comprehensive range of cardiac interventional techniques, making it the leading department in the province’s interventional cardiology field with the most procedures performed, the highest case volume, and the highest success rate. Currently available procedures include coronary interventional diagnosis and therapy via radial or femoral artery approaches, radiofrequency ablation for tachyarrhythmias, catheter radiofrequency ablation for atrial fibrillation (guided by CARTO mapping systems), implantation of complex and various types of permanent pacemakers (including ICDs and biventricular pacemakers), interventional closure for congenital heart diseases (ASD, VSD, PDA), interventional therapy for major vascular diseases (aortic aneurysm, aortic dissection), and percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic obstructive cardiomyopathy. The department admits a large number of patients with complex and critical conditions from within the province and surrounding regions each year. Over the past three years, complex cases accounted for 31.6% of all admissions, while critical cases such as acute ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, acute heart failure, and hypertensive crises accounted for 11.8%. The cure and improvement rate reached as high as 96%. Meanwhile, the department actively assists lower-level hospitals in developing and improving their interventional diagnosis and treatment capabilities for heart diseases.

Over the past three years, the department has undertaken 3 sub-projects of the National Eleventh Five-Year Plan, 1 sub-project of the 863 Program, and nearly 40 research projects from the National Natural Science Foundation, the Wu Jieping Medical Foundation, and provincial/ministerial-level sources. The total discretionary research funding is approximately RMB 5 million. In 2011, it received RMB 5 million in funding from the Ministry of Health for the National Key Clinical Specialty. The department holds 2 national invention patents and has edited or contributed to over 10 high-level academic works. It has received 1 First Prize for Scientific and Technological Achievements from the Health Department, 2 Second Prizes for Scientific and Technological Progress from Jilin Province, 2 Third Prizes for Scientific and Technological Progress from Jilin Province, 3 Jilin Provincial Scientific and Technological Achievement Awards, 1 First Prize for Scientific and Technological Progress from the city, 1 Second Prize in the Jilin Provincial Invention Creation Competition, 1 Seventh Jilin Provincial Natural Science Academic Achievement Award, 7 Second Prizes for Medical Achievements from Jilin University, and 5 Third Prizes for Medical Achievements from Jilin University. More than 70 papers have been published, including over 30 presented at academic conferences, with more than 10 indexed by SCI, EI, and ISTP.

The department regularly invites internationally renowned interventional experts for academic exchanges. It currently maintains friendly cooperative relationships with the Cardiovascular Center of Hyogo University (Japan), the Cardiovascular Disease Research Center of the University of Ottawa (Canada), the Heart Research Center of the University of Munich (Germany), the Columbia University Heart Center (USA), the Texas Heart Institute (USA), the Cardiovascular Research Institute of the University of Kentucky (USA), and the Department of Internal Medicine of National Taiwan University Hospital. These collaborations ensure that the department's cardiovascular interventional techniques remain at the domestic leading level. The department systematically arranges for young and middle-aged physicians to pursue advanced studies in cutting-edge diagnosis and treatment technologies. Each physician attends about 6-8 domestic conferences per year, and about 15 physicians are sent to international cardiovascular conferences annually. Gradually, the department has formed specialized teams for coronary intervention, arrhythmia intervention, and structural heart disease intervention.

Leveraging the advantages of being a Key Specialty of the Jilin Provincial Health Department and a National Key Clinical Specialty, the Department of Cardiovascular Medicine will continue to strictly adhere to relevant regulations, further strengthen disciplinary construction, exemplify the leading role of these designations, and enhance the level of cardiovascular diagnosis and treatment across the province.